查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722788

非处方药 (OTC) 市场规模、份额、趋势及预测（按产品类型、给药途径、剂型、配销通路和地区），2025 年至 2033 年

Over The Counter (OTC) Drugs Market Size, Share, Trends and Forecast by Product Type, Route of Administration, Dosage Form, Distribution Channel, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球非处方药 (OTC) 市场规模价值 1,780 亿美元。展望未来， IMARC Group估计到 2033 年市场规模将达到 2,882.9 亿美元，2025 年至 2033 年的复合年增长率为 5.23%。北美目前占据非处方药 (OTC) 市场的主导地位，到 2024 年将达到 42.2%。该地区市场的发展受到消费者对自我药疗的强烈偏好、高昂的医疗保健支出、广泛的零售供应以及对非处方药的有利监管支持的推动。

非处方药 (OTC)，也称为非处方药，无需处方或寻求医疗保健专业人员的治疗即可使用。它们安全有效，有助于治疗疼痛、咳嗽、感冒、腹泻、便秘、痤疮以及控制復发性偏头痛和过敏。目前，它们在全球各地的药局、便利商店、超市和加油站均有贩售。

非处方药（OTC）市场趋势：

越来越多的人使用非处方药治疗轻微疾病是推动市场成长的关键因素之一。除此之外，非处方药，如抗酸剂、组织胺-2（H2）阻断剂和质子帮浦抑制剂（PPI），可用于缓解和预防胃灼热或酸性消化不良。此外，由于冠状病毒病（COVID-19）的爆发，人们对自我保健重要性的认识有所提高。这反过来又增加了营养补充剂的销售量并增强了市场成长。此外，主要参与者正在扩大其产品组合，以扩大其消费者群体并增加其地理影响力。再加上监管机构越来越多地批准将处方药转换为非处方药，这对市场产生了积极的影响。除此之外，由于医疗成本的增加，目前选择非处方药而不是咨询医生的人数正在增加。此外，自我药疗实践有助于控制慢性疾病，减少旷工，并避免在轻微疾病期间耗尽稀缺的医疗资源。其他一些因素，例如全球老年人口的增加、分销管道的快速扩张以及製药行业的显着增长，正在推动整体销售和盈利能力的增长。

本报告回答的关键问题

  • 非处方药（OTC）市场有多大？非处方药（OTC）市场的未来前景如何？
  • 推动非处方药（OTC）市场的关键因素有哪些？
  • 哪个地区占据非处方药（OTC）市场的最大份额？
  • 哪些是全球非处方药（OTC）市场的领导公司？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球非处方药（OTC）市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品类型

  • 咳嗽、感冒和流感产品
  • 止痛药
  • 皮肤科产品
  • 胃肠产品
  • 维生素、矿物质和补充剂（VMS）
  • 减肥/膳食产品
  • 眼科产品
  • 助眠产品
  • 其他的

第七章：市场区隔：依行政途径

  • 口服
  • 肠外
  • 外用
  • 其他的

第八章：市场区隔：按剂型

  • 片剂和胶囊
  • 液体
  • 软膏
  • 其他的

第九章：市场区隔：按配销通路

  • 医院药房
  • 零售药局
  • 网路药局
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Alkem Laboratories Limited
    • Bayer AG
    • Daiichi Sankyo Company Limited
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Novartis AG
    • Perrigo Company plc
    • Pfizer Inc.
    • Piramal Enterprises Ltd.
    • Reckitt Benckiser Group PLC
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112025A5189

The global over the counter (OTC) drugs market size was valued at USD 178.00 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 288.29 Billion by 2033, exhibiting a CAGR of 5.23% from 2025-2033. North America currently dominates the over the counter (OTC) drugs market share at 42.2% in 2024. The market in the region is driven by strong consumer preference for self-medication, high healthcare expenditures, widespread retail availability, and favorable regulatory support for non-prescription medications.

Over the counter (OTC) drugs, also known as non-prescription drugs, can be used without a prescription or the need for seeking treatment by a healthcare professional. They are safe and effective and help cure pain, cough and cold, diarrhea, constipation, acne and manage recurring migraines and allergies. They are currently available in pharmacies, convenience stores, supermarkets and gas stations across the globe.

Over The Counter (OTC) Drugs Market Trends:

The increasing utilization of OTC drugs to treat minor ailments among individuals represents one of the key factors bolstering the market growth. Besides this, OTC medications, such as antacids, histamine-2 (H2) blockers, and proton pump inhibitors (PPIs), are used to relieve and prevent heartburn or acid indigestion. In addition, due to the coronavirus disease (COVID-19) outbreak, there is a rise in awareness among individuals about the importance of self-care. This, in turn, is increasing the sales of nutritional supplements and strengthening the market growth. Moreover, key players are expanding their product portfolio to widen their consumer base and increase their geographical presence. This, coupled with the increasing approvals from regulatory bodies for switching prescription drugs to OTC drugs, is positively influencing the market. Apart from this, there is currently an increase in the number of people opting for OTC drugs rather than consulting physicians on account of increasing healthcare costs. Furthermore, self-medication practices can assist in controlling chronic diseases, reducing absenteeism from work, and saving scarce medical resources from being exhausted during minor conditions. Some of the other factors, such as the rising geriatric population worldwide, rapid expansion of distribution channels, and significant growth in the pharmaceutical industry, are driving the overall sales and profitability.

Key Market Segmentation:

Breakup by Product Type:

  • Cough, Cold and Flu Products
  • Analgesics
  • Dermatology Products
  • Gastrointestinal Products
  • Vitamins, Minerals and Supplements (VMS)
  • Weight-loss/Dietary Products
  • Ophthalmic Products
  • Sleeping Aids
  • Others

Breakup by Route of Administration:

  • Oral
  • Parenteral
  • Topical
  • Others

Breakup by Dosage Form:

  • Tablets and Capsules
  • Liquids
  • Ointments
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Alkem Laboratories Limited, Bayer AG, Daiichi Sankyo Company Limited, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1.How big is the over the counter (OTC) drugs market?
  • 2.What is the future outlook of the over the counter (OTC) drugs market?
  • 3.What are the key factors driving the over the counter (OTC) drugs market?
  • 4.Which region accounts for the largest over the counter (OTC) drugs market share?
  • 5.Which are the leading companies in the global over the counter (OTC) drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Over The Counter (OTC) Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Cough, Cold and Flu Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Analgesics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Dermatology Products
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Gastrointestinal Products
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Vitamins, Minerals and Supplements (VMS)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Weight-loss/Dietary Products
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Ophthalmic Products
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Sleeping Aids
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast
  • 6.9 Others
    • 6.9.1 Market Trends
    • 6.9.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parenteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Topical
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Dosage Form

  • 8.1 Tablets and Capsules
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Liquids
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ointments
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Alkem Laboratories Limited
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Daiichi Sankyo Company Limited
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Dr. Reddy's Laboratories Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 GlaxoSmithKline plc
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Novartis AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Perrigo Company plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Piramal Enterprises Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Reckitt Benckiser Group PLC
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Sanofi S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Sun Pharmaceutical Industries Ltd.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Teva Pharmaceutical Industries Ltd.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Over The Counter Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Over The Counter Drugs Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Over The Counter Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Over The Counter Drugs Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Over The Counter Drugs Market: Breakup by Route of Administration (in %), 2024
  • Figure 6: Global: Over The Counter Drugs Market: Breakup by Dosage Form (in %), 2024
  • Figure 7: Global: Over The Counter Drugs Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Over The Counter Drugs Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Over The Counter Drugs (Cough, Cold and Flu Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Over The Counter Drugs (Cough, Cold and Flu Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Over The Counter Drugs (Analgesics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Over The Counter Drugs (Analgesics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Over The Counter Drugs (Dermatology Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Over The Counter Drugs (Dermatology Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Over The Counter Drugs (Gastrointestinal Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Over The Counter Drugs (Gastrointestinal Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Over The Counter Drugs (Weight-loss/Dietary Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Over The Counter Drugs (Weight-loss/Dietary Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Over The Counter Drugs (Ophthalmic Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Over The Counter Drugs (Ophthalmic Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Over The Counter Drugs (Sleeping Aids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Over The Counter Drugs (Sleeping Aids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Over The Counter Drugs (Other Product Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Over The Counter Drugs (Other Product Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Over The Counter Drugs (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Over The Counter Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Over The Counter Drugs (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Over The Counter Drugs (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Over The Counter Drugs (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Over The Counter Drugs (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Over The Counter Drugs (Other Route of Administrations) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Over The Counter Drugs (Other Route of Administrations) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Over The Counter Drugs (Tablets and Capsules) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Over The Counter Drugs (Tablets and Capsules) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Over The Counter Drugs (Liquids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Over The Counter Drugs (Liquids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Over The Counter Drugs (Ointments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Over The Counter Drugs (Ointments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Over The Counter Drugs (Other Dosage Forms) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Over The Counter Drugs (Other Dosage Forms) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Global: Over The Counter Drugs (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Global: Over The Counter Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Global: Over The Counter Drugs (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Global: Over The Counter Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Global: Over The Counter Drugs (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Global: Over The Counter Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Global: Over The Counter Drugs (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Global: Over The Counter Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: North America: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: North America: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: United States: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: United States: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Canada: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Canada: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Asia-Pacific: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Asia-Pacific: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: China: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: China: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Japan: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Japan: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: India: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: India: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: South Korea: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: South Korea: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Australia: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Australia: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Indonesia: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Indonesia: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Europe: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Europe: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Germany: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Germany: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: France: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: France: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: United Kingdom: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: United Kingdom: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Italy: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Italy: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Spain: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Spain: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Russia: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Russia: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Others: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Latin America: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Latin America: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Brazil: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 92: Brazil: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 93: Mexico: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 94: Mexico: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 95: Others: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 96: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 97: Middle East and Africa: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 98: Middle East and Africa: Over The Counter Drugs Market: Breakup by Country (in %), 2024
  • Figure 99: Middle East and Africa: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 100: Global: Over The Counter Drugs Industry: SWOT Analysis
  • Figure 101: Global: Over The Counter Drugs Industry: Value Chain Analysis
  • Figure 102: Global: Over The Counter Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Over The Counter Drugs Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Over The Counter Drugs Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Over The Counter Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 4: Global: Over The Counter Drugs Market Forecast: Breakup by Dosage Form (in Million USD), 2025-2033
  • Table 5: Global: Over The Counter Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Over The Counter Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Over The Counter Drugs Market: Competitive Structure
  • Table 8: Global: Over The Counter Drugs Market: Key Players